Cancer patients across the UK are encountering significant challenges as they are unable to access vital medications. This crisis is largely attributed to escalating medicine prices, which have surged as
Cancer patients across the UK are encountering significant challenges as they are unable to access vital medications. This crisis is largely attributed to escalating medicine prices, which have surged as
GSK has announced promising results from early trials of a new gynaecological cancer drug, which it aims to fast-track for market release in the coming years. The pharmaceutical giant is
Health experts in France have issued a warning regarding the consumption of traditional baked goods such as croissants and baguettes. Research suggests that these popular items may contain a carcinogenic
Plans for prostate cancer screening in the UK may encounter further reductions, amid increasing demands for expanded testing initiatives. The conversation surrounding prostate cancer screening has gained prominence as more
Bayer has halted the acceptance of new patients into its early access scheme, amidst an ongoing dispute with HMRC regarding tax liabilities on free-of-charge medicines. This decision has raised concerns






